Alexion Pharmaceuticals Inc (ALXN)

NASDAQ

Currency in USD

182.50

0.00(0.00%)

Real-time Data·20/07

Fair Value

Unlock Value

Day's Range

180.13

182.67

52 wk Range

180.13

182.67

Alexion (NASDAQ:ALXN) Annual Report

This summary provides an overview of the most significant critical numbers from each of the Alexion financial reports, including the Alexion Pharmaceuticals Inc income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health.

Investors can select to view data from four periods of either annual or quarterly information, allowing them to track the NASDAQ:ALXN financials over time via breakdowns of their annual reports. Advanced annual reports and additional financial summaries (including visual charts) are available to users with an InvestingPro account.

Key Ratios

P/E Ratio59.23

Price/Book3.25

Debt / Equity23.18%

Return on Equity4.43%

Dividend Yield0.00%

EBITDA3.19B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2011

31/12

2012

31/12

2013

31/12

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

Income Statement

Total Revenues

aa.aa

3,084.1

3,551.1

4,131.2

4,991.1

6,069.9

Gross Profit

aa.aa

2,825.8

3,249

3,762.7

4,596.6

5,516.4

Operating Income

aa.aa

793.4

983.3

1,619.9

2,139.9

2,881.4

Net Income

aa.aa

399.4

443.3

77.6

2,404.3

603.4

Balance Sheet

Total Assets

aa.aa

13,253.3

13,583.3

13,931.9

17,544.6

18,103

Total Current Liabilities

aa.aa

822.9

952.5

1,174

1,194.3

1,624.7

Total Equity

aa.aa

8,693.8

8,893.1

9,165.3

11,271.8

11,651.2

Cash Flow

Levered Free Cash Flow

aa.aa

550.31

868.76

1,070.46

1,400.81

2,111.14

Cash from Operations

aa.aa

1,086.3

1,115.6

426

2,084.9

3,002.9

Cash from Investing

aa.aa

-287.6

-918.3

470.5

9.7

-2,099.5

Cash from Financing

aa.aa

-836.2

-596.6

-102.4

-739.1

-611.9

Net Change in Cash

aa.aa

-44.1

-381.6

782.9

1,356.3

311

* In Millions of USD (except for per share items)

Earnings

Latest Release

Oct 28, 2021

EPS / Forecast

-- / 3.48

Revenue / Forecast

-- / 1.73B

EPS Revisions

Unlock

Last 90 days

FTSE 100

8,758.04

-16.61

-0.19%

DAX

23,273.78

-76.77

-0.33%

Euro Stoxx 50

5,221.75

-11.83

-0.23%

S&P 500

6,013.24

+45.42

+0.76%

Nikkei 225

38,354.09

-49.14

-0.13%

Dow Jones

42,511.13

+304.31

+0.72%

FTSE 100 Futures

8,777.00

+7.0

+0.08%

Market Movers

Name	Last	Chg. %	Vol.
Shell	2,684.0	+0.04%	24.81M
Rolls-Royce Holdings	886.60	-0.14%	16.50M
HSBC	860.30	-0.76%	14.58M
BAE Systems	1,877.17	-1.10%	12.81M
GSK plc	1,403.00	+0.04%	10.50M
Experian	3,828.0	+1.59%	4.97M
AstraZeneca	10,420.0	+0.27%	1.69M

Name	Last	Chg. %	Vol.
Viridien	62.750	+13,511.71%	71.00
Fincantieri	13.95	+2,582.69%	87.66K
XXL ASA	9.81	+1,096.34%	800.00
Alpha Bank	2.723	+416.70%	0.00
Inteliqo	0.03	+400.99%	0.00
Zscaler	308.0100	+250.21%	1.14K
MFE MEDIAFOREUROPE NV B	3.846	+218.11%	24.28K

Name	Last	Chg. %	Vol.
Nikola	0.05	-99.47%	49.99K
Wolfspeed	0.56	-97.95%	2.40M
Idex ASA	0.0312	-96.64%	2.20M
Palatin	0.14	-96.59%	8.14K
Tamar Minerals	0.002	-94.29%	0.00
Mynaric	1.30	-93.63%	77.00
Aena	22.49	-90.33%	1.54M

Trending Stocks

Name	Last	Chg. %	Vol.
BP	386.40	+0.44%	27.07M
Trafalgar New Homes	0.07	+40.00%	453.06M
Metals One	18.00	0.00%	27.78M
Rolls-Royce Holdings	886.60	-0.14%	16.50M
Pri0r1ty Intelligence	9.10	+19.36%	49.51M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aaaaa Aaa	2,033.0	+50.69%	3,063.53
Aaa Aaaaaaaaa Aa	4,185.0	+50.47%	6,297.17
A A A Aaaa Aaaaaaaaa	1,403.00	+45.40%	2,039.96
Aaaa Aa	386.40	+28.03%	494.71
Aaaaaaaaaaaaaa	10,420.0	+26.26%	13,156.29
Aaaaaaaaa	168.10	+24.36%	209.05
Aaa Aaaaaa	1,848.5	+21.77%	2,250.92

Name	Last	Upside	Fair Value
Aa Aaaaa Aaa	2,033.0	+50.69%	3,063.53
Aaa Aaaaaaaaa Aa	4,185.0	+50.47%	6,297.17
A A A Aaaa Aaaaaaaaa	1,403.00	+45.40%	2,039.96
Aaaa Aa	386.40	+28.03%	494.71
Aaaaaaaaaaaaaa	10,420.0	+26.26%	13,156.29
Aaaaaaaaa	168.10	+24.36%	209.05
Aaa Aaaaaa	1,848.5	+21.77%	2,250.92

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Alexion Pharmaceuticals Inc (ALXN)

Alexion (NASDAQ:ALXN) Annual Report

Key Ratios

Statements Highlights

Earnings

Trending Stocks